|Bid||76.13 x 100|
|Ask||76.47 x 100|
|Day's range||75.89 - 76.91|
|52-week range||55.80 - 85.07|
|PE ratio (TTM)||9.82|
|Earnings date||23 Apr 2018 - 27 Apr 2018|
|Forward dividend & yield||N/A (N/A)|
|1y target est||87.06|
Starting in October 2017, Dentsply Sirona (XRAY) implemented a series of management changes with the aim of positioning the company as a stronger and more efficient organization and maintaining the company’s leadership position in dentistry. In October, the company accepted the resignations of Executive Chairman Bret W. Wise, CEO and Director Jeffrey T. Slovin, and President and COO (chief operating officer) Christopher T. Clark. Mark A. Thierer was appointed interim CEO, and Bob Size was appointed interim president and COO. Mark A. Thierer has around 30 years of healthcare industry experience and most recently served as the CEO of OptumRx.
The insurer's shares fell 10% on word that it will acquire the nation’s No. 1 pharmacy benefits manager for more than $50 billion.
A.M. Best has placed under review with developing implications the Financial Strength Rating of A- and Long-Term Issuer Credit Rating of “a-” of Medco Containment Life Insurance Company and Medco Containment Insurance Company of New York .
Civitas Solutions (CIVI) is a leading provider of home and community-based health and human services to adults and children with intellectual or developmental disabilities, brain injury, and other catastrophic injuries and illnesses. In March 2018, of the four analysts covering Civitas Solutions, two analysts have given the stock a “strong buy” rating, and two analysts have given it a “buy” rating. The mean rating for the stock is 1.5 with a target price of $18.75.
On March 7, 2018, Cigna (CI) announced that it has entered into a definitive agreement to acquire Express Scripts (ESRX) for a total consideration of $67 billion, which includes $15 billion worth of the latter’s debt. The cash and stock transaction has been structured so every Express Script common share will be purchased for $48.75 in cash and 0.24 of Cigna’s common shares. Cigna has offered Express Scripts’ shareholders a premium of ~31% over Express Scripts’ closing price as of March 7, 2018.
A dramatic gambit to bring down drug prices did the job. The problem? It's awful for the patients caught in the middle.
Over 20 years, Brian Komoto built a thriving pharmacy in California’s Central Valley. Each day, his nurses would travel the vast agricultural region’s roads to help hepatitis C patients take a grueling ...
The Nasdaq shot up to record high while the S&P 500 and Dow Jones reclaimed 50-day lines on a just-right jobs report and less-harsh Trump steel tariffs.
We think that Cigna's announced acquisition of Pharmacy Benefits Manager giant Express Scripts may signal the death throes of America's historical system for providing healthcare.
Since last year, Cigna is seeking $13 billion in damages and a $1.85 billion breakup fee from Anthem. A legal win for Cigna could help pay down the large debt load from the insurer's acquisition of Express Scripts.